Status:
COMPLETED
Blue Light Phototherapy
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
T-Cellerate LLC
Conditions:
Grover's Disease
Psoriasis Vulgaris
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
This study will use Blue-light Photo-therapy to treat patients with psoriasis vulgaris and Grover's Disease.
Eligibility Criteria
Inclusion
- Patient's aged 18-89 at time of enrollment
- Previous diagnosis of psoriasis vulgaris or Grover's disease
Exclusion
- All Groups: Subjects who are younger than 18 years of age or older than 90 years of age
- Patients who have received topical or systemic treatment within the prior 2 weeks of planned phototherapy
- Patients prescribed any of the following drugs for issues not related to their psoriasis or Grover's disease
- topical steroids
- calcineurin inhibitors
- methotrexate
- retinoids
- biologic agents
- Unable to schedule phototherapy sessions
- We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 22 2022
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04343586
Start Date
September 1 2020
End Date
September 22 2022
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Department of Dermatology
Chicago, Illinois, United States, 60611